
Hippocratic AI
Total Raised
$402MInvestors Count
25Deal Terms
3Funding, Valuation & Revenue
8 Fundings
Hippocratic AI has raised $402M over 8 rounds.
Hippocratic AI's latest funding round was a Series C for $126M on November 3, 2025.
Hippocratic AI's valuation in January 2025 was $1,640M.
Hippocratic AI's latest post-money valuation is from November 2025.
Sign up for a free demo to see Hippocratic AI's valuations in November 2025, March 2024 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/3/2025 | Series C | $126M | Avenir, Alphabet, Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, John Doerr, Kleiner Perkins, Premji Invest, Rick Klausner, Undisclosed Investors, Universal Health Services, and WellSpan Health | 4 | ||
5/7/2025 | Corporate Minority | |||||
1/9/2025 | Series B | $1,640M | ||||
9/19/2024 | Series A - II | |||||
3/18/2024 | Series A |
Date | 11/3/2025 | 5/7/2025 | 1/9/2025 | 9/19/2024 | 3/18/2024 |
|---|---|---|---|---|---|
Round | Series C | Corporate Minority | Series B | Series A - II | Series A |
Amount | $126M | ||||
Investors | Avenir, Alphabet, Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, John Doerr, Kleiner Perkins, Premji Invest, Rick Klausner, Undisclosed Investors, Universal Health Services, and WellSpan Health | ||||
Valuation | $1,640M | ||||
Revenue | |||||
Sources | 4 |
Hippocratic AI Deal Terms
3 Deal Terms
Hippocratic AI's deal structure is available for 3 funding rounds, including their Series C from November 03, 2025.
Round | Series C | Series B | Series A |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series C | |||||||||||||||
Series B | |||||||||||||||
Series A |
Hippocratic AI Investors
25 Investors
Hippocratic AI has 25 investors. Andreessen Horowitz invested in Hippocratic AI's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/16/2023 | 11/3/2025 | Andreessen Horowitz | 4 Seed VC, Series A (2024), Series B (2025), Series C (2025) | Venture Capital | California | |
5/16/2023 | 11/3/2025 | 4 Seed VC, Series A (2024), Series B (2025), Series C (2025) | Venture Capital | California | ||
3/18/2024 | 11/3/2025 | WellSpan Health | 3 Series A, Series B (2025), Series C (2025) | Non-Profit Foundation | Pennsylvania | |
Corporation | Pennsylvania | |||||
Corporation | Ohio |
First funding | 5/16/2023 | 5/16/2023 | 3/18/2024 | ||
|---|---|---|---|---|---|
Last Funding | 11/3/2025 | 11/3/2025 | 11/3/2025 | ||
Investor | Andreessen Horowitz | WellSpan Health | |||
Rounds | 4 Seed VC, Series A (2024), Series B (2025), Series C (2025) | 4 Seed VC, Series A (2024), Series B (2025), Series C (2025) | 3 Series A, Series B (2025), Series C (2025) | ||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Non-Profit Foundation | Corporation | Corporation |
Location | California | California | Pennsylvania | Pennsylvania | Ohio |
Compare Hippocratic AI to Competitors

Abridge focuses on generative artificial intelligence (AI) for clinical conversations within the healthcare sector. The company provides AI solutions that create AI-generated notes intended for use in patient-clinician interactions. It serves healthcare systems, intending to enhance clinician efficiency and nursing documentation. Abridge was formerly known as Intelligible.AI. It was founded in 2018 and is based in Philadelphia, Pennsylvania.

Hyro operates as a healthcare-focused company specializing in artificial intelligence (AI) powered communications. The company offers a platform that automates workflows and conversations for health systems, ensuring Health Insurance Portability and Accountability Act (HIPAA) compliance and integration across various channels such as call centers and mobile applications. Hyro serves the healthcare sector, providing solutions for patient interactions and operational processes. It was founded in 2018 and is based in New York, New York.

Corti develops artificial intelligence models for the healthcare sector. Its offerings include AI models that understand medical terminology and patient interactions, designed to integrate into healthcare applications via an application programming interface. The company was founded in 2016 and is based in Copenhagen K, Denmark.

Suki AI operates develops voice solutions for the healthcare sector. The company offers Suki Assistant, which supports healthcare documentation and administrative tasks, and Suki Platform, enabling healthcare technology companies to integrate artificial intelligence (AI) features. Suki AI serves the healthcare industry, providing tools for clinician efficiency and electronic health record (EHR) integration. Suki AI was formerly known as Robin AI. It was founded in 2017 and is based in Redwood City, California.

Abstractive Health focuses on artificial intelligence solutions for the healthcare sector, particularly in the area of clinical note management. The company provides a physician AI assistant that summarizes medical records, allowing for the reading and writing of clinical notes. Abstractive Health's technology integrates with existing healthcare systems, facilitating chart retrieval and AI-generated clinical summaries. It was founded in 2022 and is based in New York, New York.

Ambience operates as a healthcare technology company that provides ambient artificial intelligence (AI) solutions for clinical documentation, coding, and patient summaries. The company has a platform that integrates with electronic health records (EHRs) to support patient care, specialty workflows, documentation accuracy, and billing processes. Ambience serves the healthcare sector with tools aimed at addressing clinician burnout. It was founded in 2020 and is based in San Francisco, California.
Loading...

